Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
92 hedge funds and large institutions have $144M invested in Immunomedics Inc in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 6 closing their positions.
233% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 6
118% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 17
110% more capital invested
Capital invested by funds: $68.9M → $144M (+$75.4M)
89% more call options, than puts
Call options by funds: $7.47M | Put options by funds: $3.95M
16% more funds holding
Funds holding: 79 → 92 (+13)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$6.29M |
| 2 |
DM
Deerfield Management
New York
|
+$3M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$2.39M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$2.37M |
| 5 |
O
OrbiMed
New York
|
+$1.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.99M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$604K |
| 3 |
Charles Schwab
San Francisco,
California
|
-$118K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$70K |
| 5 |
ST
Spot Trading
Chicago,
Illinois
|
-$69.6K |
IMMU Hedge Fund Activity: Q4 2015 in Review
92 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q4 2015, worth a combined $144M — up 110% from $68.9M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new IMMU positions and 6 closed out — a net gain of 14 holders — while 37 added to existing stakes and 17 trimmed.
The largest buyer was Acuta Capital Partners, adding an estimated $6.29M. The largest seller was Fidelity Investments, cutting an estimated $2.99M.
- 92 institutional investors held Immunomedics Inc (IMMU) as of Q4 2015, up from 79 in Q3 2015.
- Funds reported $144M of Immunomedics Inc stock for Q4 2015, up 110% quarter-over-quarter.
- 20 funds opened new Immunomedics Inc positions in Q4 2015 and 6 closed out, a net change of +14 holders.
- The largest Immunomedics Inc buyer in Q4 2015 was Acuta Capital Partners, an estimated $6.29M added.
- The largest Immunomedics Inc seller in Q4 2015 was Fidelity Investments, an estimated $2.99M sold.
Based on aggregated 13F filings for Q4 2015.